COPD Trial, Recruiting NCT06776731 Sponsor: Eastern Switzerland University of Applied Sciences Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06776731
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a confirmed diagnosis of COPD, shown through breathing tests (a specific ratio of less than 0.7 on lung function testing after using an inhaler) and a smoking history of more than 10 pack-years
  • People who are currently taking part in a pulmonary rehabilitation program (a structured exercise and education program for lung conditions)
  • People aged 18 years or older
  • People whose condition has been stable for more than 3 weeks, meaning no flare-ups or worsening of symptoms recently
  • People whose blood oxygen level at rest is 88% or higher
  • People whose blood oxygen level drops by 4% or more, and/or falls below 90%, during a 6-minute walking test (a standard test where distance walked in 6 minutes is measured)
  • People who have provided written, signed consent to participate

Who may not be able to join:

  • People whose blood oxygen level at rest is below 88%
  • People who already use long-term oxygen therapy at home
  • People whose condition is currently unstable and requires changes to their medications or other treatments, or who need intensive medical care
  • People who have another serious illness occurring alongside their COPD
  • People who are unable to follow the study procedures — for example, due to language barriers, psychological conditions, or neurological or physical problems that affect walking or the ability to ride a stationary bike
  • Women who are pregnant or breastfeeding
  • People who are currently enrolled in another clinical trial that involves an active treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Silvia Ulrich, Prof., University of Zurich

Phone: +41 58 257 12 97

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Eastern Switzerland University of Applied Sciences
Registry
ClinicalTrials.gov
Start date
6 January 2025
Est. completion
1 April 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Constant Work Rate Exercise Test Endurance time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov